# A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

> **NCT01730027** · PHASE2 · COMPLETED · sponsor: **Pulmagen Therapeutics** · enrollment: 248 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ADC3680
- **DRUG:** Placebo
- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT01730027
- **Lead sponsor:** Pulmagen Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730027, "A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT01730027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*